IMRX
Immuneering Corp
4.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.4% | +0.5% | +0.3% | -1.6% | -2.9% | -0.9% | -0.8% | -6.2% | -3.4% | +6.6% | +3.4% | – | |
| – | +10.9% | -10.1% | +12.7% | -1.3% | +5.2% | -1.9% | -9.9% | -4.5% | +12.5% | -0.1% | -0.5% | – | |
| – | – | -242.5% | – | -190.8% | – | -153.3% | – | -58.7% | -93.9% | -7,832.5% | – | – | |
| – | +199.1% | -78.1% | -12.5% | -83.9% | +77.6% | -4.4% | -76.3% | +242.9% | +1,607.9% | -35.5% | -65.8% | – | |
| – | – | +582.8% | -76.8% | -209.0% | – | -100.2% | -76.3% | +242.9% | +1,222,779.8% | -28.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | -63.5% | +12,407.0% | -100.0% | – | -100.9% | – | -100.4% | – | -100.2% | – | -86.4% | – | |
| – | – | – | -195.3% | – | – | – | – | – | -149.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.